ARTICLE | Clinical News
Veliparib: Ph III data
April 21, 2017 8:31 PM UTC
Top-line data from a double-blind, international Phase III trial in 970 patients with previously untreated advanced or metastatic squamous NSCLC showed that oral veliparib plus carboplatin and paclita...
BCIQ Company Profiles
BCIQ Target Profiles